Recent research has generated widespread interest in the use of central venous oxygen saturation (ScvO 2) as a target for resuscitation in early sepsis. However, there are many factors which may affect the value of this variable and there is no published data examining the effect of varying the FiO 2 on ScvO2. The purpose of this study was to investigate the influence of increasing FiO 2 on ScvO2 in 20 stable critical care patients. Baseline arterial and central venous blood haemoglobin oxygen saturation measurements were obtained. FiO 2 was then increased to 1.0 for 30 minutes, after which arterial and central venous haemoglobin oxygen saturations were re-measured. Mean ScvO 2 increased significantly from 73.3% (SD 6.6) to 80.0% (SD 7.0); mean increase was 6.7% (95% CI 4.8 to 8.7; p ≤ 0.001). Increasing FiO 2 was associated with a significant increase in ScvO 2 and may therefore complicate the interpretation of ScvO 2 data.
Introduction
There is widespread interest in the use of central venous oxygen saturation (ScvO 2) to guide fluid and inotrope administration. The adverse prognostic significance of values of ScvO 2 below 65% has been observed in a number of trials involving patients with myocardial infarction, 1 trauma, 2 severe sepsis, 3 and cardiac failure. 4 An interventional study by Rivers and colleagues involving septic patients, 5 demonstrated a reduction in morbidity and mortality in the early goal directed therapy (EGDT) group in which ScvO 2 was optimised to greater than 70%. This has fuelled interest in the use of ScvO 2 as a target for resuscitation in early sepsis. More recently, there has been also growing interest in the association of low values of ScvO 2 with morbidity in the perioperative and postoperative periods for patients undergoing major surgery. 6, 7 In addition to cardiac output, ScvO2 is also affected by a range of factors which affect blood oxygen content and tissue oxygen consumption. There are therefore many treatments which affect ScvO 2. FiO2 was not controlled in the study by Rivers and colleagues and there has been no published data examining the effect of varying the FiO 2 on ScvO2 in humans. The physiological importance of increasing FiO 2 on ScvO2 is illustrated by the sigmoid shape of the oxy-haemoglobin dissociation curve. A small change in PO 2 would be predicted to have a much greater effect on oxygen saturation of haemoglobin on the steep part of the curve in the 50-75% saturation range (venous blood) than in the 90-100% range (arterial blood). The aim of this study was to look at whether increasing FiO 2 has an effect on ScvO2.
Methods
Following Local Research Ethics Committee approval, written informed consent, where possible, was obtained from 20 stable critical care patients. In patients unable to consent, assent was obtained from next of kin and retrospective consent was then sought. As there had been no previous published studies regarding our hypothesis we were unable to perform a calculation to determine the sample size and so the number was chosen arbitrarily. All patients had both radial arterial and central venous catheters (internal jugular or subclavian) in situ and none were due to undergo any events which would affect their oxygen consumption or delivery. Patients were not included if they were clinically unstable.
Baseline arterial and central venous blood samples were obtained and analysed by co-oximetry using a blood gas analyser (Radiometer Copenhagen ABL 700 Series) which was calibrated every 4 hours. FiO 2 was then increased to 1.0 in ventilated patients, and in the spontaneously breathing patients a Hudson RCI adult non-rebreathing mask was applied with oxygen flow at 15 l/min. After 30 minutes further arterial and central venous blood samples were taken and the patient's FiO 2 was returned to baseline. Haemoglobin concentration, SaO 2, PaO2, ScvO 2 and the partial pressure of oxygen in the central venous blood (PcvO 2) were recorded at both baseline and high FiO2.
The significance of any difference between SaO2 pre and post high FiO 2 was assessed using the paired t-test. The same statistical analyses were employed with changes in ScvO 2. Mean differences are presented with 95% confidence intervals. A two-sided 5% significance level was used. Data were analysed using Microsoft Excel.
Oxygen content (ml/100 mls of blood) was calculated using the formula (1.34 x Hb x SpO 2 x 0.01) + (0.023 x PaO 2 ) where Hb is presented in g/dl and PaO 2 in kPa. The significance of any difference between arterial blood oxygen content (CaO 2) before and after high FiO 2 was assessed using the paired t-test. The same statistical analyses were again employed with changes in central venous blood oxygen content (CcvO 2). Mean differences were presented with 95% confidence intervals. A two-sided 5% significance level was again used.
Results
We recruited 20 patients in our critical care unit, 18 of whom were spontaneously breathing via a facemask and two were intubated and ventilated. The patients had a variety of medical and surgical conditions (table 1, see page 9) and had been established on the critical care unit for more than 24 hours. All patients were haemodynamically stable and none were severely anaemic. Thirteen patients had internal jugular and seven patients had subclavian central venous catheters in situ. table 3 (see page 10 ). On analysis, both groups of data were normally distributed, with non-significant skewness tests. Mean baseline FiO 2 was 0.35. Mean SaO2 increased from 97.5% (SD 1.6) to 99.5% (SD 0.6) following 30 minutes of high flow oxygen; mean increase 2% (95% CI 1.3 to 2.6; p ≤ 0.001). Mean ScvO 2 increased significantly from 73.3% (SD 6.6) to 80.0% (SD 7.0); mean increase 6.7% (95% CI 4.8 to 8.7, p ≤ 0.001) (figure 1). Mean CaO 2 increased from 13.82 (SD 1.6) to 14.9 (SD 2.2) ml/ 100 mls of blood following 30 minutes of high flow oxygen; mean increase 1.08 ml (95% CI 0.36 to 1.81; p=0.005). Mean CcvO 2 increased from 10.59 (SD 1.4) to 11.19 (SD 1.9) ml/ 100 mls of blood; mean increase 0.6 ml (95% CI 0.22 to 0.98; p=0.004).
Discussion
The principal finding of our study was that increasing FiO 2 resulted in a mean increase in ScvO 2 of 6.7%. This observation may have significant implications for the interpretation of ScvO 2 data in clinical practice. Although we were unable to find any human studies supporting our conclusion, Rheinhart and colleagues 8 examined the correlation between ScvO 2 and mixed venous saturations (SvO 2 ) in anaesthetised dogs under different conditions including normoxia and hyperoxia at 100% O 2 . Although no statistical test was employed, an increase in the mean saturation was observed but not specifically commented on in the article. The adverse prognostic significance of low values of ScvO 2 (less than 65%) has been demonstrated in patients with myocardial infarction, 1 trauma, 2 severe sepsis, 3 and cardiac failure. 4 Recently Pearse and colleagues observed that low ScvO2 values during the first eight hours after major surgery was associated with increased risk of postoperative complications. 6 A further study has confirmed the association between low ScvO 2 and postoperative complications. 7 In the only interventional study to target ScvO2, Rivers and colleagues demonstrated a reduction in morbidity and mortality in the EGDT group of septic patients in which ScvO 2 was optimised to greater than 70%. 5 These studies emphasise the importance of a clear understanding of ScvO 2 physiology.
Although the importance of the current findings seems most likely to relate to the interpretation of ScvO2 data, it is also possible that the increase in ScvO2 may reflect a beneficial effect of oxygen therapy. Tissue hypoxia is a key feature of critical illness which arises in part due to an imbalance between oxygen delivery and demand and is a key development preceding multi-organ failure and death. 9 High oxygen partial pressures may increase the distance of interstitial oxygen diffusion with a subsequent reduction in tissue hypoxia. 10 In surgical patients, high tissue oxygen tension is associated with a reduced risk of wound infection, 11 which may be partly explained by the oxidative killing of bacteria by neutrophils. 12 Clinical trials suggest the use of a high FiO 2 in the perioperative period may also decrease the incidence of wound infection. 13, 14 The principal arguments against the use of high FiO 2 in critical care patients are the risks of absorption atelectasis and pulmonary oxygen toxicity. Absorption atelectasis may be associated with the use of high concentrations of supplemental oxygen, although a number of studies have shown no significant increase in postoperative absorption atelectasis with high FiO 2 administration over periods up to eight hours. [15] [16] [17] [18] [19] Pulmonary oxygen toxicity may only occur after prolonged exposure [20] [21] [22] and interestingly, in experimental models, sepsis may be associated with an increased resistance to hyperoxic lung injury. 23 The Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock recommend targeting a ScvO 2 of more than 70%. 24 Whilst our study suggests that this can be partly achieved by increasing FiO 2, the only protocol which has been shown to improve outcome focussed on the use of fluid and inotropic therapies to achieve this. 5 There is at present no evidence that other approaches to increasing ScvO 2 would result in similar improvements in outcome.
There are some weaknesses in the methodology of this study. As eighteen out of the twenty patients were breathing oxygen through a facemask, the values of initial FiO 2 and subsequent high FiO 2 could not be accurately assessed. However the study was designed to evaluate whether increasing FiO 2 had any effect on ScvO 2 rather than to quantify the magnitude of this effect. The position of the central venous catheter tip was not assessed prior to data collection. However, a retrospective review of chest radiographs confirmed that the tips of all twenty catheters were within the superior vena cava. The lack of cardiac output data may also limit interpretation of these findings. However, we selected haemodynamically stable patients to avoid the introduction of bias and we believe that cardiac output would have been unlikely to change significantly during the 30 minute study period.
In conclusion our study showed that FiO 2 has a significant effect on ScvO 2 and emphasises the importance of taking FiO2 into consideration when evaluating ScvO 2 data, either in research or clinical practice. Further research might assess the degree of increase in ScvO 2 with high flow oxygen in acutely unwell patients with initially low ScvO 2 rather than our cohort of haemodynamically stable patients. 
